The company is still reeling with negative cash flows and net losses. The post Mynd Life Sciences cuts losses, but faces going concern doubts appeared...
Management is trying to learn from Johnson & Johnson's latest success in the space. The post Compass widens Q4 loss as patient hurdles slow trials...
The company said its operations are funded through 2025. The post GH Research pushes forward with DMT trials, drug approvals appeared first on Green Market...
New potential therapies like MDMA will need more infrastructure beyond just buildings. The post Prepping the psychedelic industry for MDMA approval appeared...
The firm will now able to conduct research trials in the United States. The post Filament Health’s psychedelic drug candidate gains FDA nod appeared...
VANCOUVER, BC, Jan. 31, 2024 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS) (“Filament” or the “Company“), a clinical‐stage...
SAN FRANCISCO – Jaguar Health, Inc. (NASDAQ: JAGX) today announced that a preclinical study in mice initiated in Brazil by Magdalena Biosciences,...
TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) — Huxley Health Inc. (“Huxley” or the “Company”) is pleased to provide you with a comprehensive corporate...
MindBio Therapeutics Corp. announced it is nearing the completion of its Phase 2a clinical trial using MB22001 in patients with Major Depressive Disorder....
The company also named several other new executives. The post Huxley Health finalizes Sintalica deal, names Bruce Linton chairman appeared first on Green...